AAAAAA
Results:
1-7
|
Results: 7
Authors:
Brennan, PA
Palacios-Callender, M
Zaki, GA
Spedding, AV
Langdon, JD
Citation: Pa. Brennan et al., Does type II nitric oxide synthase expression correlate with cellular proliferation in oral squamous cell carcinoma and dysplasia?, HEAD NECK, 23(3), 2001, pp. 217-222
Authors:
Brennan, PA
Palacios-Callender, M
Zaki, GA
Spedding, AV
Langdon, JD
Citation: Pa. Brennan et al., Type II nitric oxide synthase (NOS2) expression correlates with lymph nodestatus in oral squamous cell carcinoma, J ORAL PATH, 30(3), 2001, pp. 129-134
Authors:
Connelly, L
Palacios-Callender, M
Ameixa, C
Moncada, S
Hobbs, AJ
Citation: L. Connelly et al., Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide, J IMMUNOL, 166(6), 2001, pp. 3873-3881
Authors:
Brennan, PA
Palacios-Callender, M
Sinclair, D
Spedding, AV
Zaki, GA
Citation: Pa. Brennan et al., Does expression of inducible nitric oxide synthase correlate with severityof oral epithelial dysplasia?, J CRAN MAX, 28(1), 2000, pp. 44-48
Authors:
Brennan, PA
Umar, T
Palacios-Callender, M
Spedding, AV
Mellor, TK
Buckley, J
Langdon, JD
Citation: Pa. Brennan et al., A study to assess inducible nitric oxide synthase expression in oral lichen planus, J ORAL PATH, 29(6), 2000, pp. 249-254
Correlation between type II nitric oxide synthase and p53 expression in oral squamous cell carcinoma
Authors:
Brennan, PA
Palacios-Callender, M
Umar, T
Hughes, D
Spedding, AV
Zaki, GA
Langdon, JD
Citation: Pa. Brennan et al., Correlation between type II nitric oxide synthase and p53 expression in oral squamous cell carcinoma, BR J ORAL M, 38(6), 2000, pp. 627-632
Authors:
van der Loo, B
Labugger, R
Skepper, JN
Bachschmid, M
Kilo, J
Powell, JM
Palacios-Callender, M
Erusalimsky, JD
Quaschning, T
Malinski, T
Gygi, D
Ullrich, V
Luscher, TF
Citation: B. Van Der Loo et al., Enhanced peroxynitrite formation is associated with vascular aging, J EXP MED, 192(12), 2000, pp. 1731-1743
Risultati:
1-7
|